HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
People

Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen

AI heavyweight Anthropic has appointed Novartis CEO Vas Narasimhan to its board of directors as the link between the pharmaceutical industry and Silicon Valley deepens.

By FiercePharma · Apr 17, 2026 · via FiercePharma
Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen

Image: FiercePharma

Tags
peopleformat:headlineheadlineFiercePharma
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from People
All People →
Teva launches new online schizophrenia community project
PeopleFiercePharma ↗
Teva launches new online schizophrenia community project
Just two months after the FDA accepted for review Teva’s long-acting version of a decades-old schizophrenia dr…
Apr 18, 2026
Omnicom brews Olixir from FCB Health, rebranding storied agency after Interpublic takeover
PeopleFiercePharma ↗
Omnicom brews Olixir from FCB Health, rebranding storied agency after Interpublic takeover
Omnicom Health has stamped its mark on the recently acquired FCB Health New York, rebranding the ad agency as …
Apr 18, 2026
Astellas manufacturing chief views reliable supply, bridging research as his production 'north star'
PeopleFiercePharma ↗
Astellas manufacturing chief views reliable supply, bridging research as his production 'north star'
For Astellas’ chief manufacturing officer, Rao Mantri, Ph.D., production is not just about a reliable supply o…
Apr 18, 2026